Literature DB >> 11511877

Ultrasound of focal liver lesions.

C J Harvey1, T Albrecht.   

Abstract

This paper gives a comprehensive overview of ultrasound of focal liver lesions. Technical aspects such as examination technique and the use of Doppler modes as well as recent developments such as tissue harmonic imaging and microbubble contrast agents are discussed. The clinical significance and sonographic features of various liver lesions such as haemangioma, focal nodular hyperplasia, adenoma, regenerative nodule, metastasis, hepatocellular carcinoma and various types of focal infections are described. With the exception of cysts and typical haemangiomas, definitive characterisation of a liver lesion is often not possible on conventional ultrasound. This situation has changed with the recent advent of ultrasound contrast agents, which permit definitive diagnosis of most lesions. Contrast-enhanced sonography using recently developed contrast-specific imaging modes dramatically extends the role of liver ultrasound by improving its specificity in the detection and characterisation of focal lesions to rival CT and MRI.

Entities:  

Mesh:

Year:  2001        PMID: 11511877     DOI: 10.1007/s003300101002

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  36 in total

1.  Malignant focal liver lesions at contrast-enhanced ultrasonography and magnetic resonance with hepatospecific contrast agent.

Authors:  M D'Onofrio; S Crosara; R De Robertis; S Canestrini; V Cantisani; G Morana; R Pozzi Mucelli
Journal:  Ultrasound       Date:  2013-12-13

2.  Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography.

Authors:  Tommaso Vincenzo Bartolotta; Massimo Midiri; Emilio Quaia; Michele Bertolotto; Massimo Galia; Filippo Cademartiri; Roberto Lagalla; Adelfio Elio Cardinale
Journal:  Eur Radiol       Date:  2005-02-15       Impact factor: 5.315

3.  [Multiple focal liver lesions of a 33 year-old female. Presentation of an unexpected differential diagnosis].

Authors:  M O Koester; M Pross; A Dormann; C Roecken; H Lippert; H Huchzermeyer
Journal:  Internist (Berl)       Date:  2005-01       Impact factor: 0.743

4.  Characterization of hypoechoic focal hepatic lesions in patients with fatty liver: diagnostic performance and confidence of contrast-enhanced ultrasound.

Authors:  Tommaso Vincenzo Bartolotta; Adele Taibbi; Massimo Galia; Giuseppe Runza; Domenica Matranga; Massimo Midiri; Roberto Lagalla
Journal:  Eur Radiol       Date:  2006-10-03       Impact factor: 5.315

Review 5.  Recent applications of ultrasound: diagnosis and treatment of hepatocellular carcinoma.

Authors:  Hitoshi Maruyama; Masaaki Ebara
Journal:  Int J Clin Oncol       Date:  2006-08       Impact factor: 3.402

6.  Liver haemangiomas undetermined at grey-scale ultrasound: contrast-enhancement patterns with SonoVue and pulse-inversion US.

Authors:  Tommaso Vincenzo Bartolotta; Massimo Midiri; Emilio Quaia; Michele Bertolotto; Massimo Galia; Filippo Cademartiri; Roberto Lagalla
Journal:  Eur Radiol       Date:  2004-12-21       Impact factor: 5.315

Review 7.  Evaluation of nonmalignant liver masses.

Authors:  Wojciech Blonski; K Rajender Reddy
Journal:  Curr Gastroenterol Rep       Date:  2006-02

Review 8.  Clinical uses of microbubbles in diagnosis and treatment.

Authors:  David Cosgrove; Chris Harvey
Journal:  Med Biol Eng Comput       Date:  2009-02-10       Impact factor: 2.602

9.  Poor sensitivity of sonography in detection of hepatocellular carcinoma in advanced liver cirrhosis: accuracy of pretransplantation sonography in 118 patients.

Authors:  Wei Chiang Liu; Jae Hoon Lim; Cheol Keun Park; Min Ju Kim; Seung Hoon Kim; Soon Jin Lee; Won Jae Lee; Hyo Keun Lim
Journal:  Eur Radiol       Date:  2003-02-05       Impact factor: 5.315

10.  Focal nodular hyperplasia in normal and fatty liver: a qualitative and quantitative evaluation with contrast-enhanced ultrasound.

Authors:  Tommaso Vincenzo Bartolotta; Massimo Midiri; Michele Scialpi; Elio Sciarrino; Massimo Galia; Roberto Lagalla
Journal:  Eur Radiol       Date:  2003-10-10       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.